189 related articles for article (PubMed ID: 7543098)
1. Specificity of the PTB domain of Shc for beta turn-forming pentapeptide motifs amino-terminal to phosphotyrosine.
Trüb T; Choi WE; Wolf G; Ottinger E; Chen Y; Weiss M; Shoelson SE
J Biol Chem; 1995 Aug; 270(31):18205-8. PubMed ID: 7543098
[TBL] [Abstract][Full Text] [Related]
2. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
[TBL] [Abstract][Full Text] [Related]
3. Binding affinities of tyrosine-phosphorylated peptides to the COOH-terminal SH2 and NH2-terminal phosphotyrosine binding domains of Shc.
Zhou MM; Harlan JE; Wade WS; Crosby S; Ravichandran KS; Burakoff SJ; Fesik SW
J Biol Chem; 1995 Dec; 270(52):31119-23. PubMed ID: 8537373
[TBL] [Abstract][Full Text] [Related]
4. The phosphotyrosine interaction domain of Shc binds an LXNPXY motif on the epidermal growth factor receptor.
Batzer AG; Blaikie P; Nelson K; Schlessinger J; Margolis B
Mol Cell Biol; 1995 Aug; 15(8):4403-9. PubMed ID: 7542744
[TBL] [Abstract][Full Text] [Related]
5. Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites.
van der Geer P; Wiley S; Gish GD; Lai VK; Stephens R; White MF; Kaplan D; Pawson T
Proc Natl Acad Sci U S A; 1996 Feb; 93(3):963-8. PubMed ID: 8577769
[TBL] [Abstract][Full Text] [Related]
6. Identification of residues in GTPase-activating protein Src homology 2 domains that control binding to tyrosine phosphorylated growth factor receptors and p62.
Marengere LE; Pawson T
J Biol Chem; 1992 Nov; 267(32):22779-86. PubMed ID: 1385407
[TBL] [Abstract][Full Text] [Related]
7. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.
Eck MJ; Shoelson SE; Harrison SC
Nature; 1993 Mar; 362(6415):87-91. PubMed ID: 7680435
[TBL] [Abstract][Full Text] [Related]
8. A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain.
O'Bryan JP; Songyang Z; Cantley L; Der CJ; Pawson T
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2729-34. PubMed ID: 8610109
[TBL] [Abstract][Full Text] [Related]
9. Evidence for a role for the phosphotyrosine-binding domain of Shc in interleukin 2 signaling.
Ravichandran KS; Igras V; Shoelson SE; Fesik SW; Burakoff SJ
Proc Natl Acad Sci U S A; 1996 May; 93(11):5275-80. PubMed ID: 8643566
[TBL] [Abstract][Full Text] [Related]
10. The phosphotyrosine interaction domain of SHC recognizes tyrosine-phosphorylated NPXY motif.
Songyang Z; Margolis B; Chaudhuri M; Shoelson SE; Cantley LC
J Biol Chem; 1995 Jun; 270(25):14863-6. PubMed ID: 7541030
[TBL] [Abstract][Full Text] [Related]
11. PTB domains of IRS-1 and Shc have distinct but overlapping binding specificities.
Wolf G; Trüb T; Ottinger E; Groninga L; Lynch A; White MF; Miyazaki M; Lee J; Shoelson SE
J Biol Chem; 1995 Nov; 270(46):27407-10. PubMed ID: 7499194
[TBL] [Abstract][Full Text] [Related]
12. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.
Sakaguchi K; Okabayashi Y; Kido Y; Kimura S; Matsumura Y; Inushima K; Kasuga M
Mol Endocrinol; 1998 Apr; 12(4):536-43. PubMed ID: 9544989
[TBL] [Abstract][Full Text] [Related]
13. The role of the Shc phosphotyrosine interaction/phosphotyrosine binding domain and tyrosine phosphorylation sites in polyoma middle T antigen-mediated cell transformation.
Blaikie PA; Fournier E; Dilworth SM; Birnbaum D; Borg JP; Margolis B
J Biol Chem; 1997 Aug; 272(33):20671-7. PubMed ID: 9252386
[TBL] [Abstract][Full Text] [Related]
14. Shc binding to nerve growth factor receptor is mediated by the phosphotyrosine interaction domain.
Dikic I; Batzer AG; Blaikie P; Obermeier A; Ullrich A; Schlessinger J; Margolis B
J Biol Chem; 1995 Jun; 270(25):15125-9. PubMed ID: 7541035
[TBL] [Abstract][Full Text] [Related]
15. Measurement of the binding of tyrosyl phosphopeptides to SH2 domains: a reappraisal.
Ladbury JE; Lemmon MA; Zhou M; Green J; Botfield MC; Schlessinger J
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3199-203. PubMed ID: 7536927
[TBL] [Abstract][Full Text] [Related]
16. Solution structure of the Shc SH2 domain complexed with a tyrosine-phosphorylated peptide from the T-cell receptor.
Zhou MM; Meadows RP; Logan TM; Yoon HS; Wade WS; Ravichandran KS; Burakoff SJ; Fesik SW
Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7784-8. PubMed ID: 7544002
[TBL] [Abstract][Full Text] [Related]
17. Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase.
Lee CH; Kominos D; Jacques S; Margolis B; Schlessinger J; Shoelson SE; Kuriyan J
Structure; 1994 May; 2(5):423-38. PubMed ID: 7521735
[TBL] [Abstract][Full Text] [Related]
18. SH-PTP2/Syp SH2 domain binding specificity is defined by direct interactions with platelet-derived growth factor beta-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phosphopeptides.
Case RD; Piccione E; Wolf G; Benett AM; Lechleider RJ; Neel BG; Shoelson SE
J Biol Chem; 1994 Apr; 269(14):10467-74. PubMed ID: 8144631
[TBL] [Abstract][Full Text] [Related]
19. Re-engineering the target specificity of the insulin receptor by modification of a PTB domain binding site.
van der Geer P; Wiley S; Pawson T
Oncogene; 1999 May; 18(20):3071-5. PubMed ID: 10340378
[TBL] [Abstract][Full Text] [Related]
20. Binding of the Src SH2 domain to phosphopeptides is determined by residues in both the SH2 domain and the phosphopeptides.
Bibbins KB; Boeuf H; Varmus HE
Mol Cell Biol; 1993 Dec; 13(12):7278-87. PubMed ID: 7504171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
